Echosens North America
@echosensNA
Followers
431
Following
400
Media
292
Statuses
637
We envision a future where medical professionals and their patients have the best tools and information to simply and effectively assess and manage liver health
Waltham, MA
Joined March 2016
To stay up-to-date on the latest trends and news in non-invasive chronic liver disease management, follow us on @Echosens global page. 👍 #liverhealthmatters
https://t.co/H4VAXAysiV
1
0
2
Are you aware of the relationship between #NAFLD, an asymptomatic condition characterized by elevated levels of fat in the liver, and #diabetes? Find out why #T2DM patients should be monitored for #NAFLD. https://t.co/p2MqzzqJSt
0
0
2
New recommendations from the USPSTF recommend screening for #HBV infection in adolescents and adults at increased risk for infection. Learn more: https://t.co/uvQl1LTCBY
aafp.org
The U.S. Preventive Services Task Force recently issued a draft recommendation statement and draft evidence review on screening for hepatitis B virus infection in nonpregnant adolescents and adults.
0
0
1
This International Nurses Day #IND2020, EASL Viewpoints https://t.co/HM6xj27mUh interviews UK #liver nurse educator Michelle Clayton on the year of the nurse, the challenges nurses face during #COVID19, their qualities & skills & offers a message for the future. @EASLedu
0
2
2
Join echosens in our next educational webinar as we welcome physician expert Dr. Caroline Apovian, the Director of Nutrition and Weight Management at Boston Medical Center. Click for details! https://t.co/gPnk7mOTlO
0
0
0
The silent liver diseases you need to know about, #NAFLD and #NASH. Affecting the livers of more than 100 million Americans, NAFLD and NASH can lead to cirrhosis of the #liver and liver cancer. Get the facts so you can prevent these diseases: https://t.co/xgu5CzOqhK
1
0
0
Fatty liver disease is a chronic liver disease and a rapidly growing problem. Find out how Dr. Richard Gilroy of Intermountain Healthcare's liver transplantation program is addressing this problem. https://t.co/ZfndYrZXg7
#liverhealthmatters #NAFLD
0
0
1
A recent study unveiled that #FibroScan was highly effective at non-invasively assessing liver fibrosis in #alcoholic patients and that instant screening of liver fibrosis in heavy drinkers is feasible without a liver biopsy. Learn more: https://t.co/RsOYTzs6we
0
0
0
Clinically #alcoholicliverdisease patients can be asymptomatic or present with acute severe alcoholic hepatitis with and without #cirrhosis.
0
0
0
April is #alcoholawarenessmonth! Did you know an estimated 7% of the US population meets the criteria for #alcoholabuse? These individuals are at increased risk of developing #alcoholicliverdisease, the 8th most common cause of mortality in the US. #liverhealthmatters
2
0
0
From all of us at Echosens, a special thank you to all the doctors and healthcare professionals for everything they are doing to fight #COVID19. #healthcareheroes
0
0
3
Worldwide, 292M people are chronically infected with chronic hepatitis B. Find out the impact #NASH has on these individuals in the latest webinar from Dr. Robert Gish, the Medical Director of The Hepatitis B Foundation. Register Today: https://t.co/ecR1E8E6mk
0
2
4
Discover new innovative tools that support diagnosis efficiency, improve accuracy and reduce costs in the battle against #liverdisease. https://t.co/RqfrVTcUJx
#liverhealthmatters
0
0
1
Thank you to Dr. Gish & the good folks @EchosensNA for making this webinar happen. @HepBFoundation
Join Echosens as we welcome Dr. Robert Gish, the Medical Director for the Hepatitis B Foundation, as he presents new findings on the intersection of #HBV, #NASH and #T2DM. Learn More: https://t.co/SFvSCWdY33
0
1
1
Join Echosens as we welcome Dr. Robert Gish, the Medical Director for the Hepatitis B Foundation, as he presents new findings on the intersection of #HBV, #NASH and #T2DM. Learn More: https://t.co/SFvSCWdY33
0
0
3
Echosens proudly announces its collaboration with MetaPhy Health to support turn-key, comprehensive #chronicliverdisease management services to #gastroenterology practices for their patients with #fattyliverdisease. Learn More: https://t.co/1G9muuWlY8
0
0
4
Today is #diabetesalertday! Did you know that the prevalence of #NAFLD has increased in parallel with the epidemics of #T2DM and #obesity? Help us raise awareness of the relationship between #NAFLD and #diabetes. Learn more: https://t.co/AfIHtXpUbe
#liverhealthmatters
0
1
2
Today is #diabetesalertday! Did you know that the prevalence of #NAFLD has increased in parallel with the epidemics of #T2DM and #obesity? Help us raise awareness of the relationship between #NAFLD and #diabetes. Learn more: https://t.co/CHg9lk9OAG
#liverhealthmatters
0
2
0
Echosens has arranged an independent assessment conducted by Santa Barbara Actuaries, a healthcare consulting firm specializing in predictive modeling and analytics, to determine the cost savings of #FibroScan care models at the #pointofcare. Learn More: https://t.co/rZxevUvzz2
0
1
1
Happy to announce that @CovidHep is now endorsed by @EASLedu Alongside our American partners @SecureCirrhosis and @AASLDtweets we can hopefully begin to understand the impact of COVID-19 in patients with liver disease. Join the effort, visit at
0
3
10